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ABSTRACT
The flap endonucleases (FENs) participate in a wide
range of processes involving the structure-specific
cleavage of branched nucleic acids. They are also
able to hydrolyse DNA and RNA substrates from the
50-end, liberating mono-, di- and polynucleotides
terminating with a 50 phosphate. Exonuclease IX is a
paralogue of the small fragment of Escherichia coli
DNA polymerase I, a FEN with which it shares 66%
similarity. Here we show that both glutathione-
S-transferase-tagged and native recombinant
ExoIX are able to interact with the E. coli single-
stranded DNA binding protein, SSB. Immobilized
ExoIX was able to recover SSB from E. coli lysates
both in the presence and absence of DNA. In vitro
cross-linking studies carried out in the absence of
DNA showed that the SSB tetramer appears to bind
up to two molecules of ExoIX. Furthermore, we
found that a 30–50 exodeoxyribonuclease activity
previously associated with ExoIX can be separated
from it by extensive liquid chromatography. The
associated 30–50 exodeoxyribonuclease activity was
excised from a 2D gel and identified as exonuclease
III using matrix-assisted laser-desorption ionization
mass spectrometry.
INTRODUCTION
The ﬂap endonucleases (FENs) are a family of structure-
speciﬁc nucleases capable of cleaving a variety of branched
DNA structures (1,2). These enzymes recognize substrates
containing at least one duplex and a single-stranded
50 overhang such as ﬂaps and pseudo Y structures. The
major activity involves cleavage of the phosphodiester
backbone one nucleotide into the double-stranded region
at the junction of single-stranded bifurcation with
duplex DNA (3,4). They also display 50–30 exonucleolytic
activities on substrates with free 50-ends (5) and can attack
gaps in duplex DNA and covalently closed-circular
DNA (6,7). These latter activities appear to be very
similar to the gap endonuclease activities described
recently in human FEN1 (8). A functional FEN seems
to be essential for all organisms. For example, the FEN
activity present within the Streptococcus pneumoniae
DNA polymerase I N-terminal region is essential for
cell viability (9), haploinsuﬃcient mice rapidly develop
tumours while FEN
 /FEN
  mutants show embryonic
lethality (10).
The striking similarity of the structures of FEN enzymes
from a diverse range of organisms has been revealed
through crystallographic structure determination. For
example, Archaeoglobus fulgidus, Methanococcus jan-
naschii, Pyrococcus furiosus, T5 exonuclease (T5FEN),
Thermus aquaticus DNA polymerase I FEN domain and
human FEN1 enzymes share a central beta sheet feature
adorned by a number of helices and interconnecting loops
(11–16). All possess binding sites for two divalent metal
ions composed of conserved glutamyl and aspartyl
residues and a DNA-binding feature known as a helix-
three-turn-helix motif (17). Based on the observation of
two manganese binding sites in Taq Pol, Steitz and co-
workers (15) proposed a two-metal-ion mechanism for
FEN-mediated phosphate ester cleavage similar to that of
the Klenow 30–50 proof-reading exonuclease (18). The
roles of the divalent metal ions include substrate binding
by metal ions I and II (19) with the site I metal generating
a hydroxide ion essential for catalysis (20). It also appears
that just one metal binding site is required for the
structure-speciﬁc endonuclease activity of the T5FEN
enzyme, whereas it requires both metal binding sites to be
occupied for exonucleolytic cleavage (19).
The DNA polymerase I protein present in eubacteria
possesses FEN activity carried within the N-terminal
domain (1). Two groups independently reported the
identiﬁcation of a previously uncharacterized Escherichia
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of sequences deposited in the public databases (21,22).
The putative gene, originally designated exo, was identi-
ﬁed based upon up to 60% sequence identity with part of
the 50 region of polA, the gene encoding Pol I. The exo
gene appeared to have a suitable ribosomal binding site
with a GUG start codon but the open reading frame
consisted only of 753 nucleotides, with no homology to
polA detectable beyond this region (21). In comparison,
polA encodes a much larger protein, consisting of the FEN
domain or 50–30 exonuclease domain also known as the
small fragment and the larger, Klenow fragment carrying
the 30–50 proofreading and DNA-dependent DNA
polymerase activity (5,23). Overall, the 251 amino-acid
protein encoded by the exo open reading frame displayed
66% similarity with the E. coli DNA Pol I protein and
most importantly, it appeared to contain most of the
residues characteristic of the FENs (24). Interestingly,
these include conserved acidic residues involved in binding
to one of the essential divalent metal ions usually required
for catalysis (site I) but lacks three acidic residues
corresponding to site II in T5FEN. Figure 1 shows the
crystal structure of the T5FEN with the residues in
common with ExoIX identiﬁed.
The exo gene was renamed xni and preliminary
characterization of the gene product, expressed as a
GST-fusion protein has been reported. A 30–50 exodeoxy-
ribonuclease activity was reported for the xni-encoded
protein and it was renamed exonuclease IX (ExoIX) (25).
In addition to this principal exodeoxyribonucleolytic
function the protein possessed a deoxyribophosphodies-
terase (dRPase) activity on abasic sites (25) and was able
to remove 30 phosphoglycolate end groups from DNA
(26). These activities are diﬃcult to reconcile with the
strong sequence homology ExoIX shares with the FEN
family of nucleases, since they are structurally dissimilar
from the apurinic/pyrimidinic endonucleases, which gen-
erally perform these types of reactions (27). We were
intrigued by the reported 30–50 exonucleolytic activity of
ExoIX as it appeared to display the reverse of the normal
polarity of action seen in the FENs i.e. 50–30. In the work
reported here, we over-produced native ExoIX and found
that by using both one and two-dimensional activity gels,
we were able to monitor the protein and nuclease activity
during fractionation. Contrary to earlier work (25), the
ExoIX protein could be separated from a contaminating
30–50 exonuclease activity. We were able to identify the
associated 30–50 exonuclease activity as being due to low
levels of initially co-purifying exonuclease III (ExoIII).
Once free of contaminating ExoIII, the ExoIX protein
displayed no apparent exodeoxyribonuclease activity
under conditions typical for FENs. We also investigated
whether ExoIX was able to interact directly with ExoIII
or any other proteins present in E. coli cell-free extracts.
Amongst others, ExoIX bound to single-stranded DNA-
binding protein (SSB). The interaction was conﬁrmed
using in vitro chemical cross-linking. The interaction took
place even in the absence of nucleic acids. The SSB
tetramer was able to bind up to two monomers of ExoIX.
MATERIALS AND METHODS
Cloning andexpression ofthe native exo/xni gene
The xni gene was ampliﬁed by PCR from E. coli XL-1Blue
genomic DNA (Stratagene) using standard procedures
(28) with Taq polymerase (Promega). The forward primer
d(TGAATTCTTTAAGGAGATTATAATGGGCTGTT
CA) included the underlined ATG start codon, ribosomal
binding site and an EcoRI recognition sequence. The
reverse primer d(TAGGGATCCGGCTCGCCGTTA)
was designed to incorporate a BamHI recognition site
downstream of the xni stop codon. After ampliﬁcation,
the PCR product was treated with the above restriction
enzymes and ligated into similarly treated expression
vector pJONEX4 (6), transformed into E. coli
BL21(pcI857) and transformants were selected on LB
agar plates containing ampicillin at 100mgml
–1. Dideoxy
sequencing was used to identify a clone, designated
Figure 1. Structure of T5FEN showing residues in common with ExoIX. The residues conserved in ExoIX and T5FEN are shown coloured in red
or blue are mapped onto the T5FEN crystal structure (pdb code 1exn). Residues in red are the ligands forming the binding site for metal ion I
(site I ligands) and are common to both proteins. Left hand panel shows a ribbon representation of the T5FEN backbone and the three metal site II
ligands (yellow spaceﬁll) that are absent in ExoIX. In T5FEN, these are aspartates (155, 201 and 204) whereas in ExoIX they are glycine 130,
isoleucine 175 and serine 178. A space-ﬁlled representation is shown on the right. The ﬁgure was generated using MacPyMOL software (http://
www.delanoscientiﬁc.com).
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A culture derived from a single colony of E. coli
BL21 (pJONEX/xni pcI857) was grown in 20l 2  YT
(16g tryptone, 10g yeast extract, 5g NaCl/l) containing
25mgml
 1 kanomycin, 100mgml
–1 ampicillin and
100mgml
–1 carbenicillin in a New Brunswick Scientiﬁc
BIOFLO 4500 Fermenter/Bioreactor, incubated at 308C,
until it reached an A600nm of 1.0, at which point the
temperature was raised to 428C for 1.5h. The vessel was
then allowed to cool passively to RT, and incubated
overnight. Cells were harvested by centrifugation and
washed with 0.9% w/v NaCl, aliquoted into 10–15g
portions and stored at –808C.
Purification of ExoIX
Cell-free extracts were prepared free of nucleic acids
essentially as described previously from  10g cell pellets
and stored as an ammonium sulphate slurry (30).
The slurry was re-suspended in 50ml ice-cold 250mM
KH2PO4/K2HPO4, pH 6.5, containing 2mM EDTA,
5mM DTT, 5% v/v glycerol, 250mM NaCl (HKP
buﬀer). The suspension was dialysed against excess HKP
buﬀer, diluted 1:10 in low salt phosphate buﬀer, LSPB,
(25mM KH2PO4/K2HPO4, pH 6.5, containing 1mM
EDTA, 5mM DTT and 5% v/v glycerol), and applied
to 5ml HiTrap SP HP and heparin HP columns assembled
in tandem then washed with LSPB. The SP column was
removed and the heparin column eluted with a 0–1M
NaCl gradient (200ml) collecting 5ml fractions. The
purest fractions were identiﬁed by SDS–PAGE, dialysed
overnight prior to anion exchange chromatography in
25mM Tris–HCl, pH 8.0, containing 200mM NaCl,
1mM EDTA, 5mM DTT and 5% w/v glycerol. A 5ml
HiTrap Q HP column was equilibrated in excess of Q
buﬀer (25mM Tris–HCl, pH 8.0, containing 1mM
EDTA, 5mM DTT and 5% w/v glycerol). The sample
was diluted 1:10 with Q buﬀer prior to loading.
The column was washed and eluted with a linear gradient
of 0–0.25M NaCl in 120ml. Fractions (5ml) were checked
for the presence of 28kDa protein by SDS–PAGE.
A 5ml HiTrap heparin HP column was equilibrated as
described above, then loaded with the pooled Q fractions
at 15%, against LSPB at 5ml min
–1. The column was
washed extensively then eluted with 0–350mM NaCl,
over 30ml, followed by 350–600mM NaCl, over 75ml,
collecting 5ml fractions. Fractions that contained pure
protein, as determined by SDS–PAGE analysis, were
stored at –208C in 50% glycerol.
Production of glutathione-S-transferase-ExoIX
fusionprotein
E. coli strain BL21 (DE3) pGEX-5-x-3(xni) was gener-
ously provided by Dr W. A. Franklin (Albert Einstein
College of Medicine, New York) and induced as
previously described (25). Cell lysis (6g cell pellet) and
ammonium sulphate precipitation were performed, as
described for native ExoIX, and the ﬁnal ammonium
sulphate pellet was re-suspended and dialysed into in
25mM sodium phosphate, pH 7.3, containing 2mM
EDTA, 5mM DTT and 150mM NaCl. Clariﬁed
supernatant (40ml) was applied to a pre-equilibrated
1ml GSTrap column (GE healthcare), run at 1ml min
–1.
The column was washed in excess of 10ml at 0.5ml min
–1
and the column eluted with 5ml 50mM Tris–HCl, pH 8.0
containing 10mM reduced glutathione. Samples
contained the purest fractions of GST-ExoIX (50kDa)
were adjusted to 25mM Tris–HCl, pH 8.0, ﬁltered
(0.2mm) and applied to a 5ml HiTrap Q anion column
at 25% against Q buﬀer. The column was washed in excess
of 50ml with Q buﬀer, then eluted over a 60ml 0–1M
NaCl gradient, at 2.5ml min
–1, collecting 3ml fractions.
Samples containing the purest bands of the fusion protein
were adjusted to 50% v/v glycerol and stored at –208C.
Nuclease assays
Radiolabelling of d(50-GATGTCAAGCAGTCCTAAC
TTTGAGGCAGAGTCC) was performed in a reaction
(30ml) containing 5pmol oligonucleotide, [1x] kinase
buﬀer (70mM Tris–HCl, pH 7.6, 10mM MgCl2,5 m M
DTT), 17pmol [g-
32P] ATP and 30 U polynucleotide
kinase at 378C for 1h. Reactions were quenched by heat
denaturation at 808C for 5min. Labelled oligonucletides
were puriﬁed using Sep-Pak Plus C18 cartridges, wetted
with HPLC-grade acetonirile (100% ACN) and equili-
brated with 10mM Tris–HCl, pH 7.6. The labelling
reaction was applied to the cartridge, washed extensively
with 3% v/v ACN and eluted with 30% v/v ACN. The
eluate was evaporated to dryness and the oligonucleotide
re-suspended in a buﬀer containing 10mM Tris–HCl,
pH 7.6. Radiolabelled nuclease assays were performed
with 1.5nM labelled oligonucleotide and varying amounts
of test protein (described in ﬁgure legend) in a buﬀer
comprising of 25mM Tris–HCl, pH 8.0, 10mM MgCl2,
100mM KCl and 0.3mgml
–1 acetylated BSA, incubated
at 378C for 10min. Reaction products were separated
by denaturing 15% PAGE, according to standard
methods (28).
The release of acid-soluble nucleotides from high
molecular weight (Type XIV; Sigma) DNA was monitored
by UV spectroscopy as described, except that the assay
contained DNA at 800mgml
–1 in 500ml 25mM Tris–HCl,
pH 8.0, 10mM MgCl2, 50mM NaCl, 2mM DTT (30).
A zymogram assay was used to identify nuclease activity
in protein bands or spots separated by 1 (31) or 2D
electrophoresis. Zymogram gels contained ca. 30mgml
–1
Type XIV DNA from herring testes (Sigma). After
electrophoresis, the proteins were re-natured in situ
and MgCl2 added to a concentration of 10mM. After
staining with ethidium bromide, exonuclease activity was
visualized as a shadow against a ﬂuorescent background
when viewed on a UV transilluminator.
Isolation and identification of theDNase associated
with ExoIX
A fraction (5ml) adjacent to the ExoIX peak, with
prominent nuclease activity and approximate molecular
weight of 28kDa, was dialysed against a 20-fold excess of
wash buﬀer, 25mM sodium phosphate, pH 7.4, contain-
ing 500mM NaCl and 5% v/v. The sample was loaded
onto a 1ml Probond column (Invitrogen), washed in
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a 0–500mM imidazole gradient (20ml), collecting
1ml fractions. Fractions were assayed by in situ DNase
activity gel and Coomassie staining methods. Protein in
the column ﬂow through (containing the ca. 28kDa
DNase activity) was precipitated by the addition of
ammonium sulphate to a 4M ﬁnal concentration,
sedimented by centrifugation at 35000 g for 30min
and the pellet re-suspended in 5ml 20mM Tris–HCl,
pH 8.0, containing 100mM NaCl and 5% v/v glycerol.
The protein sample was concentrated 10-fold, by centri-
fugation at 6000 g for 30min in a Vivaspin concentrator
device (MWCO 10000) into 25mM Tris–HCl, pH 8.0,
containing 1mM EDTA, 5mM DTT and 10% glycerol.
The sample was then analysed by 2D zymogram and
Coomassie gels.
2D electrophoresis
For each Immobilized pH Gradient (IPG) strip (17cm
ReadyStrip, non-linear pH 3–10, Bio-Rad Laboratories)
a protein sample was made up to 300ml with reswell
buﬀer, RSB (7M urea, 2M thiourea, 4% CHAPS, 30mM
DTT, 0.2% v/v ampholytes, pH 3–10). IPG strips were
actively re-hydrated at 50V for 16h at 208C in a Bio-rad
Protean II IEF cell. IEF was carried out at 250V for
15min, linear ramping from 250 to 10000V over 3h
followed by 10000V for 60000V h. The second dimension
was carried out on a 12.5% SDS–PAGE gel as described
in Allen et al. (32). Analytical gels were stained with
Biosafe Coomassie G250 stain or assayed for nuclease
activity by in situ re-naturation and ethidium bromide
staining. Protein spots were excised from the gel and
digested with trypsin. Identiﬁcation was eﬀected using
MALDI-tof generated mass spectrometry data analysed
by MS-FIT and MASCOT web-based software, allowing
for peptide mass tolerance of  150ppm, monoisotopic
masses and variable oxidation modiﬁcation.
Covalent immobilization ofExoIX andpull-down assays
ExoIX or BSA (10mg) were immobilized covalently, using
1ml of CNBr-activated Sepharose 4B, essentially as
described by the manufacturer (GE Healthcare).
Escherichia coli K12-MG1655 cell-free lysates were
prepared as described above and the protein stored
as ammonium sulphate slurry. A portion (1.8g) of
ammonium sulphate precipitate was re-suspended in a
5ml ﬁnal volume of buﬀer ABB (25mM Tris–HCl, pH 8.0
containing 100mM NaCl, 5% w/v glycerol, 2mM DTT,
with and without 1mM EDTA) and dialysed twice against
a 20-fold excess of ABB (7ml after dialysis). Preparations
in the absence of EDTA were treated with 200Uml
–1
bovine pancreatic deoxyribonuclease I (DNase I)
(Sigma-Aldrich). MgCl2 (2.5mM) and CaCl2 (0.5mM)
were added and the sample incubated for 1h at room
temperature. Lysate (1ml) was added to either ExoIX
or BSA-linked Sepharose 4B ( 40mg) and incubated with
end-over-end rotation for 1h at room temperature.
The mixture was then centrifuged (100 g for 5min)
and the supernatant removed (FT). The pelleted matrix
was washed (4   1ml ABB containing 200mM NaCl).
The ﬁnal wash buﬀer was removed, an equal volume
(ca. 40ml) of SDS-loading buﬀer added and the sample
prepared for electrophoresis on 12.5% SDS–PAGE.
Proteins were visualized by staining with Coomassie
blue. GST–ExoIX pull-downs were performed using
protein derived from E. coli MG1655-K12. Cells (10g)
were lysed as described for ExoIX preparation and soluble
proteins (50ml) dialysed extensively against 25mM
sodium phosphate, pH 7.3, containing 150mM NaCl,
2mM EDTA, 5mM DTT, 5% w/v glycerol. A ﬁnal buﬀer
change was made into binding buﬀer (as above without
NaCl) equilibrated for 4h at 48C. Soluble lysate (20ml)
was mixed with 2.0mg of GST–ExoIX, mixed by end-
over-end rotation for 1h at 48C before loading onto a 1ml
GSTrap column at a ﬂow rate of 1ml min
–1, equilibrated
with 10ml binding buﬀer. Flow through was re-applied to
the column at the same ﬂow rate and allowed to cycle
overnight. The column was washed with 10ml binding
buﬀer at 0.1ml min
–1. Bound proteins were eluted with
5ml elution buﬀer (50mM Tris–HCl, pH 8.0, containing
10mM reduced glutathione), collecting 1ml fractions.
Controls were repeated as described above using either
1.0mg GST or without the addition of supplementary
protein.
SSB–ExoIXcrosslinking
Protein samples were prepared in 60ml aliquots in PBS
to a ﬁnal concentration of 0.4mgml
–1 and dialysed twice
against a minimum 100-fold excess of buﬀer. A working
stock of cross-linking reagent, ethylene glycol bis(succini-
midylsuccinate) (EGS), was freshly prepared to 50mM
concentration in DMSO, and further dilutions obtained in
PBS of 5mM and 0.5mM. Optimization reactions (10ml)
contained 1.5mg each protein in PBS with a ﬁnal
concentration of 10, 1 or 0.1mM EGS. Reactions were
allowed to proceed at room temperature for 30min then
quenched by the addition of 50mM Tris–HCl, pH 7.5.
Samples were mixed with loading buﬀer (5ml) and
analysed directly by SDS–PAGE and either Coomassie
stained or the polyacrylamide gel was washed with
10 volumes transfer buﬀer (50mM Tris, 7mM glycine
and 20% v/v methanol) for 15min at RT and transferred
to PVDF membrane using a Bio-Rad transfer cell
according to the manufacturer0s instructions. The PVDF
membrane was blocked using 50ml PBS-T (PBS buﬀer
containing 0.05% v/v TWEEN 20) and 5% w/v milk
powder for 1h at RT or overnight at 48C. The membrane
was washed with 50ml PBS-T for 30min, followed by
incubation with 0.2mgml
–1 primary antibody (rabbit anti-
ExoIX, custom generated by York Bioscience) prepared in
20ml PBS-T with 1% w/v milk powder at RT for 1h.
The membrane was washed with PBS-T for 30min at RT,
followed by probing with 0.2mgml
–1 HRP-linked
secondary antibody (donkey anti-rabbit) prepared in
20ml PBS-T with 1% w/v milk powder, incubated at
RT for 1h. A ﬁnal wash was completed with PBS-T
for 30min. Blots were developed using ECL reagents
supplied by GE Healthcare, according to the man-
ufacturer0s instructions.
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Resolved protein bands or spots were excised from
polyacrylamide gels, digested with trypsin and analysed
by MALDI-TOF mass spectrometry (Aberdeen Proteome
Facility). Proteins were identiﬁed from peptide fragments
by comparison to theoretical digests of the E. coli
proteome in silico, using MASCOT (http://www.matrix
science.com/) or MS-ﬁt search tools (http://prospector.
ucsf.edu/).
RESULTS
Purification of DNase-free ExoIX
The xni gene was expressed at high levels using the
heat-induced pJONEX expression system. Soluble protein
was readily obtained and puriﬁed to over 98% purity
as estimated by densitomety using a combination of
ion-exchange resins (Figure 2A). Zymogram assays
(Figure 2B) on ExoIX fractions from the initial ion
exchange column revealed the presence of a DNase with
a similar, but not co-incident electrophoretic mobility with
the major protein band (Figure 2C). No DNase activity
was observed which co-migrated with ExoIX protein.
Liquid nuclease assays were carried out on samples from
each stage of the natively expressed (i.e. untagged) ExoIX
puriﬁcation. These assays showed that the ﬁnal puriﬁed
fraction lacked any signiﬁcant DNase activity (below
0.02 units, Table 1). Similarly, the GST–ExoIX fusion
protein also appeared to lack any signiﬁcant nuclease
activity. Two positive controls, T5 D15 50-30 exonuclease
(30) and exonuclease III (New England Biolabs) were also
included in the assays. These proteins showed potent
exonuclease activities of 614 and 227 units, respectively.
A range of diﬀerent divalent metal cofactors, pH and salt
conditions was examined, but in no case were we able to
detect any signiﬁcant DNase activity in fully puriﬁed
Figure 2. Chromatographic separation of 30-50 exodeoxyribonuclease activity associated with preparations of Exonuclease IX. (A) SDS–PAGE
analysis of the puriﬁcation of ExoIX from cell lysate of induced BL21 (pJONEX/xni, pcI857). SPL, cleared cell lysate applied to SP/ﬁrst Heparin
column (28mg); QL, Q load (6mg); H2L, second Heparin column load (5mg); IX, concentrated ExoIX eluate from second Heparin (7.5mg).
(B–D). Eluted fractions from ﬁrst Heparin column were separated by SDS–PAGE. (B) Ethidium bromide stained substrate gel. High molecular
weight DNA cast in the gel ﬂuoresces with UV, while regions of DNA degradation appear as darker bands. Early fractions (lanes 1–4),
contain detectable exonuclease activity. (C) The same gel counter-stained with Coomassie G250. Over-expressed ExoIX is eluted in later fractions
(lanes 5 and 6). (D) Superimposition of images in panels B and C, demonstrating that exonuclease activity can be resolved from ExoIX. A fraction
represented in lane 4 was used for subsequent enrichment and identiﬁcation of the co-purifying nuclease. Lanes, 1–6, heparin fractions (2.5ml); 7,
loading sample (5ml); 8, ﬂow through (5ml). (E) Highly puriﬁed ExoIX lacks activity on a single-stranded DNA substrate (34-mer). Protein samples
taken during the puriﬁcation of ExoIX were incubated with 15 fmol
32P-labelled 34-mer at 378C for 10min in the presence of 10mM MgCl2 and the
reaction products separated by denaturing PAGE. Reactions (10ml) contained varying amounts of protein. SPL, 0.7 and 0.07mg of protein from cell-
free extract of induced cells expressing ExoIX; QL, 0.1 and 0.01mg of protein loaded on to ﬁrst anion exchange column; H2L, 3 and 0.3mg of protein
from sample loaded onto second heparin column; IX, contains samples from ﬁnal puriﬁed fraction of ExoIX eluted from second heparin column, 5
and 0.5mg; two positive controls are also shown, bacteriophage T5 D15 exonuclease (T5), 0.1 and 0.01mg and exonuclease III (III), 0.03 and 0.003mg.
Table 1. Puriﬁcation of ExoIX
Sample Total
Yield (mg)
Purity (%)
a Speciﬁc
activity
b
Puriﬁcation of native ExoIX
Hep/SP Load 1032 12.5 0.18
QL 43 68.7 0.02
2nd Heparin Load 33 595 40.03
Heparin (F21) 5.8 598 40.02
GST–ExoIX
fusion protein
8 595 40.02
Positive Controls:
ExoIII 227
T5FEN (JRS) 614
aPurity was estimated by densitometry of Coomassie-stained
SDS-PAGE gels.
bUnits of activity per mg of protein. One unit of enzyme is deﬁned
as that required to release 1 nmol acid soluble nucleotides in 30min
at 378C.
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assay using radiolabelled oligonucleotides. This showed
that partially puriﬁed ExoIX samples did possess
a copurifying 30-50 exonuclease activity but it was ﬁnally
separated from ExoIX by the ﬁnal heparin column
(Figure 2E).
Identification of copurifyingDNase
A fraction taken from a side peak from the ﬁrst heparin
column was analysed on a 2D SDS–PAGE zymogram gel.
The result is shown in Figure 3. The spot of nuclease
activity was excised from the gel and the protein identiﬁed
as exonuclease III by mass spectrometry.
Interaction of ExoIX with E. coli lysates
A 20kDa protein from E. coli cell-free extracts was shown
to interact with both covalently immobilized ExoIX and
GST–ExoIX fusion proteins (Figure 4) but was not
retained by either control matrix (GST or Sepharose-
BSA) demonstrating that the interaction was with ExoIX
and not the matrix or fusion protein aﬃnity tag. Figure 4B
also revealed bands of  60 and 15kDa that appeared
to stick to the covalently immobilized ExoIX matrix.
They were identiﬁed as histone-like nucleoid-structuring
protein H-NS, the 17kDa protein Skp, glyceraldehyde-
30-phosphate dehydrogenase and GroEL (Table 2).
Cross-linking studies
The interaction between ExoIX and SSB was further
investigated using chemical cross-linking of the over-
expressed and recombinant proteins. SSB protein formed
Figure 3. Two-dimensional SDS-polyacrylamide gel electrophoresis
(12.5% gel) to isolate a contaminating DNase from partially puriﬁed
cell extract of E. coli BL21 pJONEX/xni pcI857. Protein (80mg) from
the concentrated ﬂow through of a Ni-chelate column was resolved by
isoelectric focusing, over a pH 3-10 non-linear gradient in the ﬁrst
dimension and separated by molecular weight by denaturing SDS-
PAGE in the second (refer to Materials and Methods for detailed
experimental conditions). (A) Substrate gel cast with 40mgml
–1 type
XIV herring sperm DNA, stained with ethidium bromide and visualized
with UV. The dark spot is caused by DNA degradation by the co-
purifying DNase. The region of activity was excised as shown (B), the
substrate gel counter-stained with Coomassie blue. (C) Replicate gel
stained with Coomassie alone. Arrows indicate the regions correspond-
ing to DNase activity (pI 5.8). Excised spots were digested with trypsin
and the fragments analysed by matrix assisted laser desorption/
ionization time-of-ﬂight (MALDI-TOF) mass spectrometry.
Figure 4. Protein interactions of ExoIX. (A) SDS–PAGE analysis of
the protein–protein interactions of GST–Exo IX and lysate of E. coli
MG1655. Cell free lysate of E. coli MG1655 was pre-incubated with
either GST–ExoIX or GST for 1h at 48C. The mixtures were loaded
onto a GSTrap column (GE Biosciences), washed and eluted with
10mM glutathione. Of the proteins which speciﬁcally eluted with
GST–Exo IX only one was visible in the ﬁnal gel image ( 20kDa).
Lanes, MG, MG1655 cell free lysate; L, GSTrap load; FT, ﬂow
through; F6/7, eluted fractions. (B) SDS–PAGE analysis of pull-down
assays with ExoIX-Sepharose. MG1655 lysate was treated with
DNase I, prior to incubation with immobilized protein. Arrows
indicate speciﬁc protein interactants which are present in the eluate
from ExoIX-Sepharose (Table 2) and absent in the BSA-Sepharose
control. Abbreviations, L, MG1655 cell lysate; FT, ﬂow through; BSA,
BSA-Sepharose 4B eluate; IX, ExoIX-Sepharose eluate.
Nucleic Acids Research, 2007, Vol. 35, No. 12 4099the expected multimer migrating close to 70kDa when
incubated alone, but when ExoIX was present two
migrating species of  100 and 150kDa were clearly seen
(Figure 5A) on SDS–PAGE analysis. Western blotting
followed by detection with anti-ExoIX polyclonal anti-
bodies conﬁrmed that the two higher species contained
ExoIX (Figure 5B). The cross linking was performed on
DNA-free samples indicating that this is a direct interac-
tion between proteins.
DISCUSSION
The ﬁrst reported biochemical study on ExoIX was
performed using a glutathione-S-transferase fusion pro-
tein. It suggested that ExoIX possessed 30-50 exonuclease
activity and a 30-phosphodiesterase activity on DNA with
a3 0-incised abasic lesion. Neither activity was quantiﬁed
in terms of turnover number nor was the enzyme puriﬁed
to constant speciﬁc activity (25). As can be seen in
Figure 2, stubborn nuclease activity was present during
the early stages of puriﬁcation, but was ﬁnally eliminated
after extensive ion exchange chromatography. Here we
have conclusively shown that the DNase activity asso-
ciated with ExoIX is due to partially copurifying
exonuclease III. The nature of the contamination was
conﬁrmed by direct identiﬁcation of the spurious nuclease
from a 2D substrate gel.
We have previously observed contaminating nuclease
activity initially copurifying with overexpressed proteins.
Though weak, such contaminating activities are readily
detected using sensitive radioisotopic assays such as those
deployed in the previous ExoIX study. We repeated the
puriﬁcation of a GST–ExoIX fusion protein using
a column format rather than the originally employed
batch recovery method (25). Extensive washing and
aﬃnity elution resulted in a protein that lacked any
detectable DNase activity as was the case with the
unmodiﬁed ExoIX protein. These results are intriguing
given that the amino acid sequence of ExoIX possesses the
ligands equivalent to those responsible for binding
the catalytically essential metal ion in the FENs (19).
We investigated whether ExoIX interacted directly with
any other E. coli proteins such as exonucelase III. Using a
pull-down format or column chromatography approaches
we were unable to reproducibly show any strong interac-
tion with exonuclease III however, several E. coli proteins
did appear to be able to bind to ExoIX. Both the native
Table 2. Identiﬁcation of proteins interacting with ExoIX
Nominal Mw (from gel) Identiﬁcation Theoretical MW Sequence coverage
a Signiﬁcance
60000 G-3-P dehydrogenase 58959 34% 5.3eþ05
b
Chaperone GroEL 57329 38% 3.1eþ04
b
22000 Single-Stranded DNA Binding Protein (SSB) 18975 53% 1.0eþ05
b
15000 Seventeen kilodalton protein (Skp) 17 677 (15 692 mature peptide) 31% 3.9e-07
 
17000 Histone-like Nucleoid Structuring Protein (H-NS) 15456 47% 0.00089
  
aPercentage of peptide fragments that cover the entire length of the theoretical gene product.
bMOWSE score (MS-Fit analysis, values 40.05 represent greater signiﬁcant).
 P-value, the probability of ﬁnding the same score in a random database, values 50.05 are signiﬁcant.
  Expect (E) value where values 50.05 are signiﬁcant.
Figure 5. Ethylene glycol bis(succinimidylsuccinate) (EGS) cross-linking
of exonuclease IX (Exo IX) and single-stranded DNA binding protein
(SSB). Proteins were prepared in PBS in the presence (EGS X-linked) or
absence (No EGS) of 1mM EGS and incubated at room temperature
for 30min. Samples were separated by 10% acrylamide SDS–PAGE.
(A) Coomassie stained gel of cross-linking. Tetrameric SSB is indicated
with open triangles, ExoIX:SSB complex with black. (B) Western blot
analysis of a replicate SDS–PAGE gel, probed with rabbit anti-ExoIX
(primary antibody) and donkey anti-rabbit-HRP (secondary antibody),
developed using the ECL system (GE Biosciences). The ExoIX:SSB
complex is indicated with arrows. Abbreviations, Exo/E, exonuclease
IX; SSB/S, single-stranded DNA binding protein; lys/L, lysozyme.
EþS; ExoIX with SSB. EþL; ExoIX plus lysozyme as a negative
control. Gels for Coomassie staining were loaded with 2.6mg protein/
lane and for westerns with 0.7mg protein/lane.
4100 Nucleic Acids Research, 2007, Vol. 35, No. 12and the GST–ExoIX fusion proteins were able to bind to
E. coli SSB. SSB forms a tetramer and is known to bind
tightly to single-stranded DNA within the E. coli cell.
ExoIX appears to be able to bind to the SSB tetramer as
two extra species are observed in the cross-linking mixture
of SSB and ExoIX compared with SSB or ExoIX alone.
Both the slowest migrating species in the ExoIX-SSB
reaction reacted with the anti-ExoIX polyclonal anti-
bodies. It should be noted that it is diﬃcult to accurately
determine the stoichiometries of binding of cross-linked
proteins by SDS–PAGE analysis. However, as two slower
migrating SSB–ExoIX complexes can be observed, the
simplest explanation is that each SSB tetramer can bind
two ExoIX molecules. We were also able to detect binding
of ExoIX to the H-NS protein, a molecule with a
preference for binding to curved duplex DNA and G/C-
rich single-stranded nucleic acids (33,34). These results
indicate that ExoIX is involved in someway with the
replication machinery, though despite our extensive eﬀorts
we have been unable to identify any substrate on which
ExoIX displays hydrolytic activity. We also identiﬁed
chaperones GroEL, GroES and Skp but these may have
been binding to ExoIX that had become partially
denatured during the immobilization process, as a
common role for chaperones is to bind disordered
peptides. The presence of glyceraldehyde-3-phosphorylase
was almost certainly due to co-migration on SDS–PAGE
of this protein with the chaperone GroEL as they share
very similar molecular masses.
This study reveals that ExoIX is not a 30-50 exonuclease
as previously suggested (25), yet it does seem to interact
intimately with the DNA binding proteins SSB and H-NS.
The homology of the protein with the FEN family of
structure-speciﬁc nucleases suggests a role in processing of
nucleic acids. Studies on an xni null mutant failed to
identify any obvious defects in a range of DNA repair
pathways (35). However, as ExoIX is a paralogue of the
FEN domain of DNA Pol I, perhaps it functions as a
back-up for this enzyme, as previously suggested (21).
Further studies are needed to determine the biological role
of this cryptic DNA Pol I paralogue.
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